PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

What Older Polypharmacy Patients Most Want to Ask Clinicians

★ Editor's Pickpolypharmacydeprescribingolder adultsquestion prompt listhealth literacymedication adherencecost-related nonadherencepatient communicationsurveygeriatric pharmacyprimary care Geriatrics / Geriatric Pharmacy

Background Information

Older adults prioritize diet and medication discussions with clinicians.

Understanding patient priorities facilitates better communication and care for older adults with multiple chronic conditions. Top interests were diet (20.4%), reducing medications (15.3%), and understanding their condition (14.6%). Focuses on older adults over 50 years taking 5+ medications; insights are useful but may not generalize to all geriatric patients. Patients want to discuss diet, medication reduction, and understanding their conditions.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Lal K, Schneider C, Espinoza AM, Hendrix ZN, Young RA, White A, Lopez CM, Xiao Y, Fulda KG

Citation: Lal K, Schneider C, Espinoza AM, et al. An Analysis of Common Questions and Concerns of Older Adults with Multiple Chronic Conditions. Journal of the American Board of Family Medicine : JABFM. 2026;39(1). doi:10.3122/jabfm.2025.250240R1

Article Links: PubMed · Journal / DOI

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →